Search

The global prevalence of diabetes mellitus and other metabolic diseases is rapidly increasing. Animal models play pivotal roles in unravelling disease mechanisms and developing and testing therapeutic strategies. Rodents are the most widely used animal models but may have limitations in their resemblance to human disease mechanisms and phenotypes. Findings in rodent models are consequently often difficult to extrapolate to human clinical trials. To overcome this ‘translational gap’, we and other groups are developing porcine disease models. Pigs share many anatomical and physiological traits with humans and thus hold great promise as translational animal models. Importantly, the toolbox for genetic engineering of pigs is rapidly expanding. Human disease mechanisms and targets can therefore be reproduced in pigs on a molecular level, resulting in precise and predictive porcine (PPP) models. In this short review, we summarize our work on the development of genetically (pre)diabetic pig models and how they have been used to study disease mechanisms and test therapeutic strategies. This includes the generation of reporter pigs for studying beta-cell maturation and physiology. Furthermore, genetically engineered pigs are promising donors of pancreatic islets for xenotransplantation. In summary, genetically tailored pig models have become an important link in the chain of translational diabetes and metabolic research.

Diatoms are unicellular algae of enormous biodiversity that occur in all water habitats on earth. Their cell walls are composed of amorphous biosilica and exhibit species-specific nanoporous to microporous and macroporous patterning. Therefore, diatom biosilica is a promising renewable material for various applications, such as in catalysis, drug-delivery systems, and biophotonics. In this study, diatom biosilica of three different species (Stephanopyxis turris, Eucampia zodiacus, and Thalassiosira pseudonana) was used as support material for gold nanoparticles using a covalent coupling method. The resulting catalysts were applied for the oxidation of d-glucose to d-gluconic acid. Because of its high specific surface area, well-established transport pores, and the presence of small, homogeneously distributed gold nanoparticles on the surface, diatom biosilica provides a highly catalytically active surface and advanced accessibility to the active sites. In comparison to those of the used reference supports, higher catalytic activities (up to 3.28 × 10–4 mmolGlc s–1 mgAu–1 for T. pseudonana biosilica) and slower deactivation were observed for two of the diatom biosilica materials. In addition, diatom biosilica showed very high gold-loading capacities (up to 45 wt %), with a homogeneous nanoparticle distribution.